Program for Drammensmøtet 2024

Scandic Hotel Ambassadeur Drammen, January 25-26, 2024

Organized by: Vestre Viken Hospital Trust, the Cancer Registry of Norway and National Network for Breast Cancer Research


Welcome to “Drammensmøtet 2024” – a multidisciplinary breast cancer symposium targeting breast surgeons, radiologists and pathologists. The symposium this year will focus on B3 lesions, artificial intelligence in radiology and pathology, and neoadjuvant treatment.

Hotel Scandic Ambassadeur in Drammen, next to Drammen Station. The hotel is reached within one hour by the Airport Express Train directly from Oslo Airport Gardermoen.

2 days symposium incl. dinner Thursday and hotel accommodation Thurs-Fri:        3500 NOK
One day symposium excl. dinner/accommodation per day:                                          1000 NOK
Dinner Thursday (for participants not staying at the hotel):                                             600 NOK
Extra hotel accommodation (for participants arriving Wednesday, January 24)        1340 NOK


Registration by 19th of November:



Preliminary program (changes may occur):

Thursday January 25th
10.00 – 10.15    Welcome

Session I: B3 lesions
Chair: Anette Heie, Haukeland University Hospital

10.15 – 10.30    Status of B3 Lesions in Norway today (Anette Heie, Haukeland University Hospital)

10.30 – 11.15    B3 Lesions and radiology (Nisha Sharma, Leeds Teaching Hospital NHS Trust, UK)

11.15 – 11.30    15 minutes Coffee break

11.30 – 12.15    B3 Lesions and pathology (Ioannis Roxanis, Royal Free London NHS Foundation Trust & The Institute of Cancer Research – Breast Cancer Now Toby Robins Research Centre, UK)

12.15 – 12.45    Discussion

13.00 – 14.00     Lunch 


Session II: Artificial intelligence in radiology and pathology
Chair: Solveig Hofvind, Cancer Registry of Norway

14.00 – 14.05     Introduction (Solveig Hofvind, Cancer Registry of Norway)

14.05 – 14.35     Studies on AI in BreastScreen Norway (Henrik Wethe Koch, Stavanger University Hospital and Marit A. Marthiniussen, Østfold Hospital)

14.35 – 15.05      AI in quality assessment of mammograms (Nisha Sharma, Leeds Teaching Hospital NHS Trust, UK)

15.05 – 15.20       15 minutes Coffee break

15.20 – 16.00       Experiences with AI in breast radiology and screening (Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany)

16.00 – 16.30     AI in pathology (Marit Valla, Norwegian University of Science and Technology)

16.30 – 17.00    Discussion

19.00 Dinner 


Friday January 26th

Session III: Neoadjuvant treatment
Chair:  Stine L’Orange, Oslo University Hospital

08.30 – 08.40    Status of Neoadjuvant treatment today (Stine L’Orange, Oslo University Hospital)

08.40 – 09.25    Neoadjuvant Therapy & Immunotherapy in breast cancer (Elena Provenzano, Cambridge University Hospitals NHS Foundation Trust, UK)

09.25 – 09.40     15 minutes Coffee break

09.40 – 10.20    Breast surgery after neoadjuvant treatment( Thorsten Kühn, Filderclinic, Germany)

10.20 – 11.00    Axillary surgery after neoadjuvant treatment (Jana de Boniface, Karolinska Institutet, Stockholm, Sweden)

11.00 – 11.30    Discussion

11.30 – 12.30    Lunch


Session IV: Case and project presentations
Chair:  Kristine K Sahlberg, Vestre Viken Hospital

12.30 – 13.00    Interval breast cancer in screening – duty of disclosure, incl discussion (Einar Vigeland, Vestfold Hospital)

13.00 – 14.00    Multidiciplinary case presentations (Helle Skjerven, Thomas Papathomas, Tone Hovda, oncologist TBA, Vestre Viken Hospital)

14.00 – 14.15    15 minutes Coffee break

14.15 – 15.45    Project presentations (6 presentations, 15 min each including discussion)

15.45 – 16.00    Closing remarks